|
The IPO will include fresh issue of equity shares aggregating upto Rs 250 crore and/or an offer of sale of equity shares by certain existing and eligible shareholders of the company.
As at 31st March 2021, Balaji Amines owned 55% stake in BSCL. It was incorporated in the year 2010, and it makes unique products like Ethylenediamine (EDA), Piperazine (Anhydrous), Diethylene Triamine (DETA) & Aminoethyliperazine (AEP). During 2021, Balaji Speciality Chemical recorded a total income of Rs 1,81,32,18,571 and net profit of Rs 11,78,45,833.
Balaji Amines is a leading manufacturer of aliphatic amines & speciality chemicals in India, specialized in manufacturing of methyl amines, ethyl amines, derivatives of amines and other specialty chemicals. It reported 29% rise in consolidated net profit to Rs 108.72 crore on a 88% increase in revenue from operations to Rs 779.04 crore in Q4 FY22 over Q4 FY21.
Balaji Amines, as a shareholder, will consider and finalise its participation in the offer of BSCL, it said.
|